Intuitive Surgical’s (ISRG Quick QuoteISRG - Free Report) push into digital monetization may meaningfully materialize in 2026 as its My Intuitive+ (MIA+) subscription transitions from bundled value-add to paid recurring revenue. Introduced alongside da Vinci 5, MIA+ integrates Telepresence, simulation and case insights to enhance surgeon performance and collaboration.

At launch, MIA+ was bundled with a one-year free period for da Vinci 5 customers. Following a significant software update in 2025, that free-use window was extended, with associated accounting deferrals shifting a portion of system revenue into service revenue over time. Beginning around mid-2026, customers will face renewal decisions and potentially start paying for continued access. Renewal rates and realized ASPs will depend on the perceived clinical and workflow value, particularly from case insights and Telepresence functionality.

This marks a pivot toward non-hardware monetization. While ISRG already derives 81% of revenue from recurring streams, MIA+ introduces a software-led layer with incremental invoicing tied to digital engagement rather than procedure volume alone. Management also highlighted synergies between case insights and Force Feedback, suggesting that as Force instruments reach full supply, the analytical value proposition could strengthen, supporting renewals.

From a financial perspective, even modest attachment and renewal rates across the expanding da Vinci 5 installed base could provide a higher-margin service tailwind. If adoption proves durable, digital subscriptions may incrementally accelerate service revenue growth in 2026 and beyond — diversifying ISRG’s monetization model beyond capital placements and instruments.

Peers Implementing Digital Infrastructure

Apart from ISRG, other robotic players like Globus Medical (GMED Quick QuoteGMED - Free Report) and Stereotaxis (STXS Quick QuoteSTXS - Free Report) are implementing digital services tied to their robotic surgery systems, which have the potential to bring additional revenues with strong margins.

Globus Medical is increasingly positioning its digital infrastructure as a catalyst for recurring monetization around its ExcelsiusGPS robotic platform. On its fourth-quarter earnings call, GMED emphasized the integration of imaging, navigation and robotics into a unified ecosystem spanning EGPS, EHUB and E3D, creating workflow continuity and data consistency across the OR.

Globus Medical highlighted more than 120,000 procedures performed with ExcelsiusGPS, underscoring a growing installed base primed for software, service and upgrade-driven revenue streams. As Globus Medical becomes more flexible with operating leases to accelerate placements, implant pull-through and digital workflow adoption should expand, supporting a subscription-like model tied to navigation software updates, service contracts and ecosystem enhancements in 2026 and beyond.

Stereotaxis is building a more explicit digital subscription thesis around GenesisX and its Synchrony/SynX platform. Stereotaxis described Genesis and GenesisX as part of a razor-razorblade model, pairing robotic system sales with high-margin recurring catheter revenue. More notably, Stereotaxis’ Synchrony and SynX digital cath lab platform introduces remote connectivity, workflow optimization and AI-enabled capabilities that management expects to evolve into a software-as-a-service revenue stream. Stereotaxis expects growing system placements and catheter adoption to lift recurring revenue above $10 million per quarter in 2026. If execution holds, Stereotaxis’ digital ecosystem tied to GenesisX could transition the company toward higher-margin, subscription-based revenues beyond 2026.